UNICA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Cagliari dal mese di luglio 2015.
| Titolo | Data di pubblicazione | Autore(i) | Rivista | Editore |
|---|
| MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212 | 2012 | LA ROSA V; POCE G; ORTIZ CANSECO J; BURONI S; PASCA MR; BIAVA M; RAJU RM; PORETTA GC; ALFONS S; B...ATTILOCCHIO C; JAVID B; SORRENTINO F; IOERGER TR; SACCHETTINI JC; MANETTI F; BOTTA M.; DE LOGU A; RUBIN EJ; DE ROSSI E. | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | |
| Ungeremine effectively targets mammalian as well as bacterial type I and type II
topoisomerases | 2011 | Casu, L; Cottiglia, F; Leonti, M.; De Logu, A; Agus, E; Tse-Dinh, YC; Lombardo, V; Sissi, C | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | |
| Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach | 2011 | Biava, M; Porretta, Gc; Poce, G; Battilocchio, C; Alfonso, S; DE LOGU, Alessandro; Manetti, F; Bo...tta, M. | CHEMMEDCHEM | |
| The MmpL3 protein is responsible for resistance to BM212, a lead antitubercular drug | 2011 | Canseco JO; La Rosa V; Luhaj A; Battaglia S; Buroni S; Biava M; De Logu A; Manetti F; Botta M; De... Rossi E | | FEMS |
| Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin | 2010 | Biava M; Porretta GC; Poce G; Battilocchio C; Alfonso S; De Logu A; Serra N; Manetti F; Botta M. | BIOORGANIC & MEDICINAL CHEMISTRY | |
| dentification of a new Chemical Class of Potent Antimycobacterial Compounds | 2010 | Biava M; Porretta GC; Poce G; Alfonso S; Battilocchio C; De Logu A; Manetti F; Botta M | | |
| BM 579: a novel pyrrole derivative with improved antimycobacterial activity | 2010 | Biava M; Porretta GC; Poce G; Alfonso S; Battilocchio C; De Logu A; Manetti F; Botta M. | | |
| New pyrrole derivatives of BM 212: a new class of antimycobacterial agents. Design, synthesis, biological evaluation and study of their mode of action. | 2010 | Biava M; Porretta GC; Poce G; Alfonso S; Battilocchio C; De Logu A; De Rossi E; Manetti F; Botta M | | |
| Effetto di Inibitori delle COX-1 e COX-2 sullo sviluppo del biofilm di Candida albicans: studio della associazione di FANS e derivati azolici per la profilassi delle infezioni fungine contratte in ambiente ospedaliero | 2010 | Agus E; Sanna A; Piras CC; Serra N; De Logu A | | |
| Design, synthesis and microbiological characterization of 1,5-diphenyl and 1,5-diaryl-2-ethylpyrrole derivatives as new potential agents of infections sustained by MDR and XDR Mycobacterium tuberculosis. | 2010 | Agus E; Biava M; Porretta GC; Poce G; Serra N; Sanna A; De Rossi E; Piras CC; Manetti F; Botta M;... De Logu A | | |
| Individuazione di nuovi target in MDR e XDR Mycobacterium tuberculosis mediante 1,5-difenil- e 1,5-diaril-2-etil-pirroli per lo sviluppo di nuovi agenti antitubercolari | 2010 | Agus E; Biava M; Porretta GC; Poce G; De Rossi E; Manetti F; Botta M; De Logu A | | |
| Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis | 2009 | CASTAGNOLO D; RADI M; DESSÌ F; MANETTI F; SADDI M; MELEDDU R; DE LOGU A; BOTTA M | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | |
| Effetto di FANS sulla formazione di biofilm di Candida albicans e potenziamento della attività di farmaci antifungini | 2009 | Agus E; Piras CC; Casula L; Serra N; De Logu A | | |
| New pyrrole derivatives of BM 212: lead compound optimization strategy, Tuberculosis drug development. Targets, technologies and trials. | 2009 | Poce G; Porretta GC; Borzi F; De Logu A; De Rossi E; Manetti F; Botta M; Biava M | | |
| Saggi e dosaggi microbiologici della Farmacopea | 2009 | DE LOGU A | | |
| Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation | 2009 | Zaru, M; Sinico, Chiara; DE LOGU, Alessandro; Caddeo, Carla; Lai, Francesco; Manca, MARIA LETIZIA...; Fadda, ANNA MARIA | JOURNAL OF LIPOSOME RESEARCH | |
| Novel N-aryl- and N-heteryl-phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and MDR Mycobacterium tuberculosis | 2009 | De Logu A; Palchykovska L H; Kostina V H; Sanna A; Meleddu R; Chisu L; Alexeeva I V; Shved A D | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | |
| Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for
the treatment of infections sustained by drug-resistant and multidrug-resistant
Mycobacterium tuberculosis | 2009 | ALESSANDRO DE LOGU; LARISA H. PALCHYKOVSKA; VALENTINA H. KOSTINA; ADRIANA SANNA; MELEDDU R; LOREN...ZA CHISU; INNA V. ALEXEEVA; ANATOLY D. SHVED | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | |
| 2-Acylhydrazino-5-arylpyrrole derivatives: Synthesis and antifungal activity evaluation | 2009 | ONNIS V; DE LOGU A; COCCO MT; FADDA R; MELEDDU R; CONGIU C | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | |
| Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones | 2009 | Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M. | BIOORGANIC & MEDICINAL CHEMISTRY | |
